Tianshui Zhongxing Bio-Technology appoints director, reshapes board

Tianshui Zhongxing Bio-Technology Co., Ltd. (SZSE:002772) announced that Shao Xiaojun, a non-independent director, resigned from the company's fifth board of directors on September 15, 2025, due to internal work adjustments. Shao, who directly holds 3,400 shares and 510,000 shares through the first employee stock ownership plan, will continue as administrative manager of Hubei Zhongxing Bio-Technology Co., Ltd., a wholly-owned subsidiary.

The company’s fourth extraordinary employee representative meeting was held on September 15, 2025, where Shao Xiaojun was elected as an employee representative director for the fifth board of directors, with his term effective immediately. Following this election, the board now comprises nine directors, satisfying the minimum statutory number and compliance with the "Company Law" and the "Articles of Association."

Additionally, a second extraordinary general meeting on September 15, 2025, saw shareholders approve proposed changes to the company's business scope and amendments to the "Articles of Association." The company will no longer have a supervisory board, with its functions transferred to the audit committee. Hou Yazhao, the former supervisor, holds 69,200 shares directly and 40,000 shares through the first employee stock ownership plan.